Effect of diet on the survival and phenotype of a mouse model for spinal muscular atrophy

Biochemical and Biophysical Research Communications

Volumn 391, Issue 1, 2010, Pages 835-840

  Butchbach, Matthew E R ^a   Rose Jr , Ferrill F ^b,c   Rhoades, Sarah ^b,c   Marston, John ^b,c   McCrone, John T ^b,c   Sinnott, Rachel ^b,c   Lorson, Christian L ^b,c  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b And Immunology   (United States)

^c UNIVERSITY OF MISSOURI   (United States)

Author keywords

Diet; Motor behavior; Motor neuron disease; Plastin 3; Spinal muscular atrophy; Survival motor neuron

Indexed keywords

GLUCOSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL SURVIVAL; FEMALE; GLUCOSE BLOOD LEVEL; LIFESPAN; MALE; MATERNAL NUTRITION; MOTONEURON; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RODENT; SPINAL CORD; SPINAL MUSCULAR ATROPHY;

3-HYDROXYBUTYRIC ACID; ANIMALS; BLOOD GLUCOSE; DIET; DISEASE MODELS, ANIMAL; FEMALE; MALE; MICE; MICE, TRANSGENIC; MUSCULAR ATROPHY, SPINAL; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

MUS; MUS MUSCULUS; RODENTIA;

EID: 72949099674     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.11.148     Document Type: Article

References (28)

1. Crawford T.O., and Pardo C.A. The neurobiology of childhood spinal muscular atrophy. Neurobiol. Dis. 3 (1996) 97-110
2. Lorson C.L., Hahnen E., Androphy E.J., et al. A single nucleotide in the SMN gene regulates splicing an is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. USA 96 (1999) 6307-6311
3. Monani U.R., Lorson C.L., Parsons D.W., et al. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8 (1999) 1177-1183
4. Lefebvre S., Bürglen L., Reboullet S., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80 (1995) 155-165
5. Coovert D.D., Le T.T., McAndrew P.E., et al. The survival motor neuron protein in spinal muscular atrophy. Hum. Mol. Genet. 6 (1997) 1205-1214
6. Lefebvre S., Burlet P., Liu Q., et al. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 16 (1997) 265-269
7. C gene copy number. Am. J. Hum. Genet. 60 (1997) 1411-1422
8. Butchbach M.E.R., and Burghes A.H.M. Perspectives on models of spinal muscular atrophy for drug discovery. Drug Disc. Today Dis. Models 1 (2004) 151-156
9. Le T.T., Pham L.T., Butchbach M.E.R., et al. SMND7, the major product of the centromeric survival motor neuron gene (SMN2), extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet. 14 (2005) 845-857
10. Butchbach M.E.R., Edwards J.D., and Burghes A.H.M. Abnormal motor phenotype in the SMND7 mouse model of spinal muscular atrophy. Neurobiol. Dis. 27 (2007) 207-219
11. Burghes A.H.M., and Beattie C.E. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?. Nat. Rev. Neurosci. 10 (2009) 597-609
12. Rose Jr. F.F., Mattis V.B., Rindt H., et al. Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy. Hum. Mol. Genet. 18 (2009) 997-1005
13. Mattis V.B., Ebert A.D., Fosso M.Y., et al. Delivery of a read-through inducing compound, TC007, lessens the severity of a SMA animal model. Hum. Mol. Genet. 18 (2009) 3906-3913
14. Wahlsten D., Metten P., Phillips T.J., et al. Different data from different labs: lessons from studies of gene-environment interactions. J. Neurobiol. 54 (2003) 283-311
15. M.E.R. Butchbach, J. Singh, M. {Thorn}orsteindóttir, et al., Effects of 2,4-diaminoquinazoline derivatives on SMN expression and phenotype in a mouse model for spinal muscular atrophy, Hum. Mol. Genet. in press.
16. -/- mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9 (2000) 333-339
17. Gavrilina T.O., McGovern V.L., Workman E., et al. Neuronal SMN expression corrects spinal muscular atrophy in severe SMA mice while muscle specific SMN expression has no phenotypic effect. Hum. Mol. Genet. 17 (2008) 1063-1075
18. Oprea G.E., Kröber S., McWhorter M.L., et al. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320 (2008) 524-527
19. Dupuis L., Oudart H., René F., et al. Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc. Natl. Acad. Sci. USA 101 (2004) 11159-11164
20. Taguchi A., Wartschow L.M., and White M.F. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317 (2007) 369-372
21. Selman C., Lingard S., Gems D., et al. Comment on "Brain IRS2 signaling coordinates life span and nutrient homeostasis". Science 320 (2008) 1012b
22. Taguchi A., and White M.F. Response to comment on "Brain IRS2 signaling coordinates life span and nutrient homeostasis". Science 320 (2008) 1012c
23. Duysen E.G., Stribley J.A., Fry D.L., et al. Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Dev. Brain Res. 137 (2002) 43-54
24. Narver H.L., Kong L., Burnett B.G., et al. Sustained improvement of spinal muscular atrophy mice treated with trichostatin A plus nutrition. Ann. Neurol. 64 (2008) 465-470
25. Avila A.M., Burnett B.G., and Taye A.A. Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy. J. Clin. Invest. 117 (2007) 659-671
26. Welling P.G. Influence of food and diet on gastrointestinal drug absorption: a review. J. Pharmacokinet. Biopharm. 5 (1977) 291-334
27. Bruce A.K., Jacobsen E., Dossing H., et al. Hypoglycaemia in spinal muscular atrophy. Lancet 346 (1995) 609-610
28. Ørngreen M.C., Zacho M., Hebert A., et al. Patients with severe muscle wasting are prone to develop hypoglycemia during fasting. Neurology 61 (2003) 997-1000